Latin American Consensus On Guidelines For Chronic Migraine Treatment

dc.creatorGiacomozzi A.R.E.
dc.creatorVindas A.P.
dc.creatorDa Silva Jr. A.A.
dc.creatorBordini C.A.
dc.creatorBuonanotte C.F.
dc.creatorDe Paula Roesier C.A.
dc.creatorBrito C.M.
dc.creatorPerez C.
dc.creatorCarvalho D.S.
dc.creatorDe Macedo D.D.P.
dc.creatorPiovesan E.
dc.creatorSarmento E.M.
dc.creatorMelhado E.M.
dc.creatorEckeli F.D.
dc.creatorKowacs F.
dc.creatorSobrino F.
dc.creatorRabello G.D.
dc.creatorRada G.
dc.creatorDe Souza J.A.
dc.creatorCasanovas J.R.
dc.creatorDuran J.C.
dc.creatorCalia L.C.
dc.creatorMedina L.R.P.
dc.creatorDe Queiroz L.P.
dc.creatorCiciarelli M.C.
dc.creatorValenca M.M.
dc.creatorCusicanqui M.
dc.creatorJimenez M.K.V.
dc.creatorGoycochea M.T.
dc.creatorPeres M.F.P.
dc.creatorSandoval M.V.F.
dc.creatorVincent M.B.
dc.creatorGomes M.V.
dc.creatorDiez M.
dc.creatorAranaga N.
dc.creatorBarrientos N.
dc.creatorKowacs P.A.
dc.creatorFilho P.F.M.
dc.date2013
dc.date2015-06-25T19:11:46Z
dc.date2015-11-26T15:09:13Z
dc.date2015-06-25T19:11:46Z
dc.date2015-11-26T15:09:13Z
dc.date.accessioned2018-03-28T22:19:25Z
dc.date.available2018-03-28T22:19:25Z
dc.identifier
dc.identifierArquivos De Neuro-psiquiatria. , v. 71, n. 7, p. 478 - 486, 2013.
dc.identifier0004282X
dc.identifier10.1590/0004-282X20130066
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84884296650&partnerID=40&md5=18feb64b7bfad44f1f8cc1f49b94c199
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/88656
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/88656
dc.identifier2-s2.0-84884296650
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1257762
dc.descriptionChronic migraine is a condition with significant prevalence all around the world and high socioeconomic impact, and its handling has been challenging neurologists. Developments for understanding its mechanisms and associated conditions, as well as that of new therapies, have been quick and important, a fact which has motivated the Latin American and Brazilian Headache Societies to prepare the present consensus. The treatment of chronic migraine should always be preceded by a careful diagnosis review; the detection of possible worsening factors and associated conditions; the stratification of seriousness/ impossibility to treat; and monitoring establishment, with a pain diary. The present consensus deals with pharmacological and nonpharmacological forms of treatment to be used in chronic migraine.
dc.description71
dc.description7
dc.description478
dc.description486
dc.description(2004) International Classification of Headache Disorders, 24, pp. S1-S160. , International Headache Society Classification Subcommittee 2nd edition. Cephalalgia
dc.description(2011) Atlas of Headache Disorders and Resources in the World, , World Health Organization Geneva: WHO
dc.description2011
dc.descriptionStovner, L.J., Hagen, K., Jensen, R., The global burden of headache: A documentation of headache prevalence and disability worldwide (2007) Cephalalgia, 27, pp. 193-210
dc.descriptionNatoli, J.L., Manack, A., Dean, B., Global prevalence of chronic migraine: A systematic review (2010) Cephalalgia, 30, pp. 599-609
dc.descriptionLipton, R.B., Bigal, M.E., Diamond, M., Migraine prevalence, disease burden, and the need for preventive therapy (2007) Neurology, 68, pp. 343-349. , AMPP Advisory Group
dc.descriptionSilva Junior, A.A., Tavares, R.M., Lara, R.R., Faleiros, B.E., Gomez, R.S., Teixeira, A.L., Frequency of types of headache in the tertiary care center of the hospital das clinicas of the universidade federal de minas gerais, MG, Brazil (2012) Rev Assoc Med Bras, 58, pp. 709-713
dc.descriptionDavies, P., Medication overuse headache: A silent pandemic (2012) Pain, 153, pp. 7-8
dc.descriptionAltena, M., Katsarava, Z., Nappi, G., COMOESTAS consortium. From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on latin American countries (2009) J Headache Pain, 10, pp. 71-76
dc.descriptionManack, A., Buse, D.C., Serrano, D., Türkei, C.C., Lipton, R.B., Rates, predictors, and consequences of remission from chronic migraine to episodic migraine (2011) Neurology, 76, pp. 711-718
dc.descriptionBuse, D.C., Manack, A., Serrano, D., Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers (2010) J Neurol Neurosurg Psychiatry, 81, pp. 428-432
dc.descriptionStokes, M., Becker, W.J., Lipton, R.B., Cost of health care among patients with chronic and episodic migraine in canada and the USA: Results from the international burden of migraine study (IBMS) (2011) Headache, 51, pp. 1058-1077
dc.descriptionCevoli, S., Sancisi, E., Pierangeli, G., Chronic daily headache: Risk factors and pathogenic considerations (2006) Neurol Sci, 27, pp. S168-S173
dc.descriptionSilberstein, S.D., Upton, R.B., Sliwinski, M., Classification of daily and near-daily headaches: Field trial of revised IHS criteria (1996) Neurology, 47, pp. 871-875
dc.descriptionSaper, J.R., The mixed headache syndrome: A new perspective (1982) Headache, 22, pp. 284-286
dc.descriptionMathew, N.T., Transformed migraine (1993) Cephalalgia, 13, pp. S78-S83
dc.descriptionOlesen, J., Bousser, M.G., Diener, H.C., Headache classification committee. New appendix criteria open for a broader concept of chronic migraine (2006) Cephalalgia, 26, pp. 742-746
dc.descriptionGl, S., Park, J.W., Shin, H.E., Differences in clinical features and disability according to the frequency of medication use in patients with chronic migraine (2012) J Clin Neurol, 8, pp. 198-203
dc.descriptionPozo-Rosich, P., Migrana crónica: Epidemiologia e impacto (2012) Rev Neurol, 54, pp. S3-S11
dc.descriptionGoadsby, P.J., Charbit, A.R., Andreou, A.P., Neurobiology of migraine (2009) Neuroscience, 161, pp. 327-341
dc.descriptionLipton, R.B., Tracing transformation: Chronic migraine classification, progression, and epidemiology (2009) Neurology, 72, pp. S3-S7
dc.descriptionSrikiatkhachom, A., Chronic daily headache: A scientist's perspective (2002) Headache, 42, pp. 523-537
dc.descriptionKruit, M.C., Van Büchern, M.A., Launer, U., Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study (2010) Cephalalgia, 30, pp. 129-136
dc.descriptionSpector, J.T., Kahn, S.R., Jones, M.R., Migraine headache and ischemic stroke risk: An updated meta-analysis (2010) Am J Med, 123, pp. 612-624
dc.descriptionChen, Y.C., Tang, C.H., Ng, K., Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan (2012) J Headache Pain, 13, pp. 311-319
dc.descriptionYoon, G., Baggaley, S., Bacchetti, P., Clinic-based study of family history of vascular risk factors and migraine (2005) J Headache Pain, 6, pp. 412-416
dc.descriptionBigal, M.E., Kurth, T., Santanello, N., Migraine and cardiovascular disease: A population-based study (2010) Neurology, 74, pp. 628-635
dc.descriptionTembl, J., Lago, A., Sevilla, T., Migraine, patent foramen ovale and migraine triggers (2007) J Headache Pain, 8, pp. 07-12
dc.descriptionGarg, P., Servoss, S.J., Wu, J.C., Lack of association between migraine headache and patent foramen ovale: Results of a case-control study (2010) Circulation, 121, pp. 1406-1412
dc.descriptionMerikangas, K.R., Angst, J., Isler, H., Migraine and psychopathology. Results of the zurich cohort study of young adults (1990) Arch Gen Psychiatry, 47, pp. 849-853
dc.descriptionTeixeira, A.L., Costa, E.A., Alberto Da Silva Jr., A., Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples (2012) J Headache Pain, 13, pp. 551-555
dc.descriptionOttman, R., Lipton, R.B., Ettinger, A.B., Comorbidities of epilepsy: Results from the epilepsy comorbidities and health (EPIC) survey (2011) Epilepsia, 52, pp. 308-315
dc.descriptionVon Brevem, M., Neuhauser, H., Epidemiological evidence for a link between vertigo and migraine (2011) J Vestib Res, 21, pp. 299-304
dc.descriptionKister, I., Caminero, A.B., Herbert, J., Tension-type headache and migraine in multiple sclerosis (2010) Curr Pain Headache Rep, 14, pp. 441-448
dc.descriptionDe Tommaso, M., Sardaro, M., Serpino, C., Fibromyalgia comorbidity in primary headaches (2009) Cephalalgia, 29, pp. 453-464
dc.descriptionPeres, M.R., Young, W.B., Kaup, A.O., Fibromyalgia is common in patients with transformed migraine (2001) Neurology, 57, pp. 1326-1328
dc.descriptionRiedl, A., Schmidtmann, M., Stengel, A., Somatic comorbidities of irritable bowel syndrome: A systematic analysis (2008) J Psychosom Res, 64, pp. 573-582
dc.descriptionStuginski-Barbosa, J., Macedo, H.R., Bigal, M.E., Signs of temporomandibular disorders in migraine patients: A prospective, controlled study (2010) Clin J Pain, 26, pp. 418-421
dc.descriptionGoncalves, D.A., Camparis, C.M., Speciali, J.G., Temporomandibular disorders are differentially associated with headache diagnoses: A controlled study (2011) Clin J Pain, 27, pp. 611-615
dc.descriptionKatsarava, Z., Schneeweiss, S., Kurth, T., Incidence and predictors for chronicity of headache in patients with episodic migraine (2004) Neurology, 62, pp. 788-790
dc.descriptionBigal, M.E., Serrano, D., Buse, D., Acute migraine medications in evolution from episodic to chronic migraine: A longitudinal population-based study (2008) Headache, 48, pp. 1157-1168
dc.descriptionScher, A.I., Stewart, W.F., Ricci, J.A., Factors associated with the onset and remission of chronic daily headache in a population-based study (2003) Pain, 106, pp. 81-89
dc.descriptionBigal, M.E., Lipton, R.B., Obesity is a risk factor for transformed migraine but not chronic tension-type headache (2006) Neurology, 67, pp. 252-257
dc.descriptionAl, S., Lipton, R.B., Stewart, W.F., Habitual snoring as a risk factor for chronic daily headache (2003) Neurology, 60, pp. 1366-1368
dc.descriptionScher, A.I., Stewart, W.F., Lipton, R.B., Caffeine as a risk factor for chronic daily headache: A population-based study (2004) Neurology, 63, pp. 2022-2027
dc.descriptionTietjen, G.E., Peterlin, B.L., Brandes, J.L., Depression and anxiety: Effect on the migraine-obesity relationship (2007) Headache, 47, pp. 866-875
dc.descriptionScher, A.I., Stewart, W.F., Buse, D., Major life changes before and after the onset of chronic daily headache: A population-based study (2008) Cephalalgia, 28, pp. 868-876
dc.descriptionLipton, R.B., Silberstein, S.D., Saper, J.R., Why headache treatment fails (2003) Neurology, 60, pp. 1064-1070
dc.descriptionYu, S., Liu, R., Zhao, G., The prevalence and burden of primary headaches in China: A population-based door-to-door survey (2012) Headache, 52, pp. 582-591
dc.descriptionStuginski-Barbosa, J., Dach, F., Bigal, M., Chronic pain and depression in the quality of life of women with migraine - A controlled study (2012) Headache, 52, pp. 400-408
dc.descriptionValença, M.M., Valença, L.P.A.A., Bordini, C., Cefaleia de "dificil controle," (2003) MigrCefaleias, 6, pp. 117-120
dc.descriptionSilberstein, S.D., Dodick, D.W., Pearlman, S., Defining the pharmacologically intractable headache for clinical trials and clinical practice (2010) Headache, 50, pp. 1499-1506
dc.descriptionRecomendacöes para o tratamento da crise migranosa (2000) Arq Neuropsiquiatr, 58, pp. 371-389. , Consensu da Sociedade Brasileira
dc.descriptionRecomendacöes para o tratamento profilático da migránea (2002) Arq Neuropsiquiatr, 60, pp. 159-169. , Consensu da Sociedade Brasileira
dc.descriptionPascual, J., Migrana crónica: Tratamiento (2012) Rev Neurol, 54, pp. S31-S38
dc.descriptionSchwartz, T.H., Karpistikiy, W., Sohn, R.S., Intravenous valproate sodium in the treatment of daily headache (2002) Headache, 42, pp. 519-522
dc.descriptionDemirkaya, S., Vural, O., Dora, B., Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks (2001) Headache, 41, pp. 171-177
dc.descriptionPaemeleire, K., Crevits, L., Goadsby, P.J., Practical management of medication-overuse headache (2006) Acta Neurol Belg, 106, pp. 43-51
dc.descriptionLane, R.L., Ross, R., Intravenous chlorpromazine - Preliminary results in acute migraine (1985) Headache, 25, pp. 302-304
dc.descriptionMonzillo, P.H., Nemoto, P.H., Costa, A.R., Acute treatment of migraine in emergency room: Comparative study between dexametasone and haloperidol. Preliminary results (2004) Arq Neuropsiquiatr, 62, pp. 513-518
dc.descriptionHill, C.H., Miner, J.R., Martel, M.L., Olanzapine versus dropendol for the treatment of primary headache in the emergency department (2008) Acad Emerg Med, 15, pp. 806-811
dc.descriptionSilberstein, S.B., Peres, M.R., Olanzapine in the treatment of refractory headache (2002) Headache, 42, pp. 515-518
dc.descriptionMendes, P.M., Silberstein, S.D., Young, W.B., Intravenous propofol in the treatment of refractory headache (2002) Headache, 42, pp. 638-641
dc.descriptionDusitanond, P., Young, W.B., Neuroleptics and migraine (2009) Cent Nerv Syst Agents Med Chem, 9, pp. 63-70
dc.descriptionKrymchantowski, A.V., Jevoux, C., Moreira, P.R., An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine (2010) Pain Med, 11, pp. 48-52
dc.descriptionObermann, M., Katsarava, Z., Management of medication-overuse headache (2007) Expert Rev Neurother, 7, pp. 1145-1155
dc.descriptionPageler, L., Katsarava, Z., Diener, H.C., Prednisone vs. Placebo in withdrawal therapy following medication overuse headache (2008) Cephalalgia, 28, pp. 152-156
dc.descriptionKatsarava, Z., Holle, D., Diener, H.C., Medication overuse headache (2009) Curr Neurol Neurosci Rep, 9, pp. 115-119
dc.descriptionZeeberg, P., Olesen, J., Jensen, R., Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness (2006) Cephalalgia, 26, pp. 1192-1198
dc.descriptionRossi, R., Jensen, R., Nappi, G., A narrative review on the management of medication overuse headache: The steep road from experience to evidence (2009) J Headache Pain, 10, pp. 407-417
dc.descriptionDodick, D.W., Türkei, C.C., DeGryse, R.E., Onabotulinumtoxma for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program (2010) Headache, 50, pp. 921-936. , PREEMPT Chronic Migraine Study Group
dc.descriptionDiener, H.C., Dodick, D.W., Aurora, S.K., Onabotulinumtoxin A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial (2010) Cephalalgia, 30, pp. 804-814. , PREEMPT 2 Chronic Migraine Study Group
dc.descriptionSilberstein, S.D., Lipton, R.B., Dodick, D.W., Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial (2007) Headache, 47, pp. 170-180. , TopiramateChronic Migraine Study Group
dc.descriptionSilvestrini, M., Bartolini, M., Coccia, M., Topiramate in the treatment of chronic migraine (2003) Cephalalgia, 23, pp. 820-824
dc.descriptionDiener, H.C., Bussone, G., Van Oene, J.C., Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study (2007) Cephalalgia, 27, pp. 814-823. , TOPMAT-MIG-201 (TOP-CHROME) Study Group
dc.descriptionYurekli, V.A., Akhan, G., Kutluhan, S., The effect of sodium valproate on chronic daily headache and its subgroups (2008) J Headache Pain, 9, pp. 37-41
dc.descriptionSilberstein, S.D., Neto, W., Schmitt, J., Topiramate in migraine prevention: Results of a large controlled trial (2004) Arch Neurol, 61, pp. 490-495. , MIGR-001 Study Group
dc.descriptionBrandes, J.L., Saper, J.R., Diamond, M., Topiramate for migraine prevention: A randomized controlled trial (2004) JAMA, 291, pp. 965-973. , MIGR-002 Study Group
dc.descriptionSilberstein, S.D., Hulihan, J., Karim, M.R., Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study (2006) Clin Ther, 28, pp. 1002-1011
dc.descriptionSilberstein, S., Lipton, R., Dodick, D., Topiramate treatment of chronic migraine: A randomized, placebo-controlled trial of quality of life and other efficacy measures (2009) Headache, 49, pp. 1153-1162
dc.descriptionHering, R., Kuntzky, A., Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo (1992) Cephalalgia, 12, pp. 81-84
dc.descriptionSilberstein, S.D., Collins, S.D., Long-term safety of depakote in headache prophylaxis study group (1999) Headache, 39, pp. 633-643. , Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study
dc.descriptionFreitag, F.G., Collins, S.D., Carlson, H.A., Depakote, E.R., A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis (2002) Neurology, 58, pp. 1652-1659. , Migraine Study Group
dc.descriptionRowe, A., Lachinski, R., Rizelio, V., Hospital management of intractable headaches. The institute de neurologia de curitiba approach (2011) Head Med, 2, pp. 194-199
dc.descriptionLionetto, L., Negro, A., Palmisani, S., Emerging treatment for chronic migraine and refractory chronic migraine (2012) Expert Opin Emerg Drugs, 17, pp. 393-406
dc.descriptionAurora, S.K., Dodick, D.W., Türkei, C.C., Onabotulinumtox in A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial (2010) Cephalalgia, 30, pp. 793-803. , PREEMPT 1 Chronic Migraine Study Group
dc.descriptionDiener, H.C., Dodick, D.W., Aurora, S.K., Onabotulinumtox in A for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial (2010) Cephalalgia, 30, pp. 804-814. , PREEMPT 2 Chronic Migraine Study Group
dc.descriptionDiener, H.C., Detoxification for medication overuse headache is not necessary (2012) Cephalalgia, 32, pp. 423-427
dc.descriptionAurora, S., Letter to the editor (2011) Cephalalgia, 31, pp. 378-379
dc.descriptionCutrer, F.M., Mathew, P., Garza, I., Cutaneous allodynia as a prognostic factor in the treatment of migraine with botulinum toxin (abstract n. PO-69) (2010) 52nd Annual Service Meeting of the American Headache Society Los Angeles;
dc.descriptionFrampton, J.E., Onabotulinumtox in A (BOTOX*): A review of its use in the prophylaxis of headaches in adults with chronic migraine (2012) Drugs, 72, pp. 825-845
dc.descriptionMathew, N.T., Jaffri, S.F., Adouble-blind comparison of onabotulinumtox in A (BOTOX) and topiramate (T0PAMAX) for the prophylactic treatment of chronic migraine: A pilot study (2009) Headache, 49, pp. 1466-1478
dc.descriptionYang, C.P., Chang, M.H., Liu, P.E., Acupuncture versus topiramate in chronic migraine prophylaxis: A randomized clinical trial (2011) Cephalalgia, 31, pp. 1510-1521
dc.descriptionRossi, R., Di Lorenzo, G., Malpezzi, M.G., Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy (2005) Cephalalgia, 25, pp. 493-506
dc.descriptionGaul, C., Eismann, R., Schmidt, T., Use of complementary and alternative medicine in patients suffering from primary headache disorders (2009) Cephalalgia, 29, pp. 1069-1078
dc.descriptionWells, R.E., Bertisch, S.M., Buettner, C., Complementary and alternative medicine use among adults with migraines/severe headaches (2011) Headache, 51, pp. 1087-1097
dc.descriptionKristoffersen, E.S., Grande, R.B., Aaseth, K., Management of primary chronic headache in the general population: The akershus study of chronic headache (2012) J Headache Pain, 13, pp. 113-120
dc.languageen
dc.publisher
dc.relationArquivos de Neuro-Psiquiatria
dc.rightsaberto
dc.sourceScopus
dc.titleLatin American Consensus On Guidelines For Chronic Migraine Treatment
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución